Replies to Here is a better link to nitric oxide orphan status granted by FDA https://globenewswire.com/news-release/2017/10/03/1140090/0/en/AIT-Therapeutics-Inhaled-Nitric-Oxide-Therapy-Granted-Orphan-Drug-Designation-by-the-U-S-Food-and-Drug-Administration-for-Treating-Infections-Caused-by-Nontuberculous-Mycobacteria-.html Shari

← Return to (MAC/MAI) Mycobacterium Avium Complex Pulmonary Disease: Join us

Discussion

(MAC/MAI) Mycobacterium Avium Complex Pulmonary Disease: Join us

MAC & Bronchiectasis | Last Active: Nov 21, 2024 | Replies (9354)

Comment receiving replies

@pfists

Here is a better link to nitric oxide orphan status granted by FDA
https://globenewswire.com/news-release/2017/10/03/1140090/0/en/AIT-Therapeutics-Inhaled-Nitric-Oxide-Therapy-Granted-Orphan-Drug-Designation-by-the-U-S-Food-and-Drug-Administration-for-Treating-Infections-Caused-by-Nontuberculous-Mycobacteria-.html
Shari

Jump to this post

Replies to "Here is a better link to nitric oxide orphan status granted by FDA https://globenewswire.com/news-release/2017/10/03/1140090/0/en/AIT-Therapeutics-Inhaled-Nitric-Oxide-Therapy-Granted-Orphan-Drug-Designation-by-the-U-S-Food-and-Drug-Administration-for-Treating-Infections-Caused-by-Nontuberculous-Mycobacteria-.html Shari"

Jo Ann K | @jkiemen | Oct 6, 2017

That is good news. I hope they try it for the MAI pts that don’t have severe symptoms yet. It would be nice to eradicate it before that point.

Jo Ann K

VIEW AND REPLY